News
World-First Achievement: SUSMED’s Blockchain-Based Clinical Trial System Supports Successful Marketing Authorization for Pharmaceutical Product
26/11/05
SUSMED has announced that “SUSMED SourceDataSync®” (“SUSMED SDS”), its proprietary blockchain-based clinical trial system, has contributed to obtaining marketing authorization for a pharmaceutical product.
The detail can be read here.
Latest Article